CLOSE
Friday, June 23, 2017
Quote Search
Tags Posts tagged with "buy marijuana stocks"

buy marijuana stocks

0 1148

OTTAWA, ONTARIO–(Marketwired – Jun 14, 2017) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(TBP.CN)(CNSX:TBP)(TBPMF) today announced that it has appointed Mr. Carl A. Merton to the Board of Directors, effective immediately.

Mr. Merton has over 20 years of financial and business experience, including 10 years experience as a CFO for public companies involved in the capital markets. Beginning with 12 years combined with Ernst & Young and KPMG, he transitioned from the audit stream into financial advisory work, as a Business Valuator, Forensic Accountant and Corporate Finance functions. After leaving KPMG, Mr. Merton joined Atlas Tube Inc., as Vice-President, Special Projects. After assisting in the sale of Atlas Tube, Mr. Merton became the CFO of Reko International Group Inc. In December 2014, Mr. Merton was elected by shareholders as a member of the inaugural Board of Directors of Aphria Inc. Approximately one year later, Mr. Merton resigned as a member of the Board and joined Aphria as its CFO. In his role as CFO, Mr. Merton is responsible for communication with all stakeholders and is a member of the executive management team responsible for the strategic direction of Aphria, as well as leading all acquisition discussions, budgeting, financing, financial reporting and internal controls. Mr. Merton is a Chartered Professional Accountant, a Chartered Accountant and is a Fellow of the Canadian Institute of Chartered Business Valuators (the “CICBV”). He holds a B.Comm. Hon. in Sports Administration from Laurentian University, and has served as a past Chair of both the CICBV and the International Association of Professional Business Valuators. Mr. Merton is currently a member of the Board of Directors and Chair of the Audit Committee of Motor City Community Credit Union.

“We are most pleased to welcome Mr. Merton to the board as we continue to work closely with our strategic partner, Aphria in building Tetra as a leading bio-pharmaceutical organization,” said Andre Rancourt, Chairman and CEO of Tetra Bio-Pharma. “Mr. Merton’s tremendous experience as a CFO of publicly listed companies has resulted in raising in excess of $200 million. His vast network both in the U.S. and Canada will be a key factor in the Company’s growth. We look forward to working closely with him in building Tetra as a global leader in pharmaceutical cannabis.”

About Tetra Bio-Pharma:
Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP)(TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Source: Tetra Bio-Pharma

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

0 1224

Canadian Cannabis & An Under The Radar Biotech Company

 

Millions of investors across the globe have had their eyes and investment dollars fixated on the Canadian cannabis industry for a myriad of reasons. For starters, medical marijuana is federally legal in Canada with the Trudeau administration signalling that the end goal is full scale legalization in a two prong approach of giving the people what they want and crippling the black markets. This progressive and pragmatic approach is what has investors in the United States salivating for as the consensus is that first mover advantage in an emerging market such as Cannabis will yield massive gains and fuel innovation in many different verticals within the industry. Still not convinced? Raise your hand if you were around for the Dot com era and investing (or aware of it for that matter), now raise your hand if you were around in the 1930’s and investing once prohibition ended. Cannabis and Marijuana Stocks are a once in a generation investment opportunity hands down!

 

Click Here Now To Read Full Article

PotNetwork Holding, Inc. (POTN) Diamond CBD to be Featured at SeeThruEquity’s Conference

PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce today that it will attend SeeThruEquity’s Annual Micro Cap Investor Conference, June 1st in New York City, where it will showcase its wholly owned subsidiary, Diamond CBD, Inc. Presenting on behalf of the Company will be its newly appointed Chief Consultant for Special Projects, Bruce Barren.

 

Click Here Now To Read Full (POTN) Release

Marijuana Policies Being Reworked In 5 Countries

 

Marijuana policy isn’t something that’s just impacting the United States. Here’s what’s happening across the globe in 5 other countries working to implement in the nea-term

 

 

Click Here Now To Read Full Article

0 2028
marijuana-stocks-north-america-cannabis

The cannabis sector continues to heat up and from earnings to acquisitions, from partnerships to insider selling, there are a number of developments investors need to be aware of.

Although we are seeing cannabis reform all over the globe, North America has been at the epicenter of such activity for the last few years. The industry incredible growth has led to creation of new sub-industries as well as opportunities.

A Differentiated and Massive Opportunity

One of the new opportunities that has taken the market by storm is Cannabis Wheaton (CBW.V) (KWFLF) and today, one of the company’s streaming partners announced a corporate update comprised of several significant developments.

Cannabis Wheaton recently released its list of streaming partners and one of them, Beleave Inc. (BLEVF) (BE.CN: CSE) just received a cultivation license from Health Canada earlier. This is a milestone for both companies and it increases the number of streaming partners with a cultivation license to three (two partners have sales licenses)

Earlier this month, Beleave signed an agreement with Cannabis Wheaton to finance the purchase and construction of a second production facility in return for equity in a joint venture corporation and a production yield allocation of the new proposed site.

The new facility will be designed to accommodate 200,000 sq. ft. of cultivation space and this is a stock that investor should be keeping an eye on.

United Cannabis Reports Misleading Earnings

Earlier this month, United Cannabis Corp (CNAB) reported its financial and operating results for the period that ended on March 31st. We rarely report on this company and it is not because there is nothing to report on, but due to the lack of execution and poor communication.

When the company does have news to report, it is typically related to a member of the executive team (CEO, COO, or VP) selling stock. We wanted to provide an earnings highlight on United Cannabis to provide better insight into why we are cautious with the firm:

  • During the quarter, the company recorded an $815,976 net loss on $189,677 in revenue. United Cannabis reported a gross profit of $68,626 and a $519,600 loss from operations.
  • As of March 31st, United Cannabis reported to have $35,584 of cash on hand, a working capital deficit of $781,998, and an accumulated deficit of $10,216,055. The company also has over $550,000 worth of notes payable to management and accrued wages payable
  • In the report, the company discussed the insider selling and said the sellers re-invested a large portion of after tax proceeds ($178,383 and $71,007, during the past two quarters). The funds were used to pay obligations and expenses, and make advances in the amount of $135,971 to its Caribbean Research & Development Company, subsidiary in Jamaica.

The Management Team is Not Always the Best Indicator

Despite having a former Presidential candidate and former state Senator involved with the business, Cananbis Sativa remains one of the worst opportunities in the sector.

Earlier this week, Cannabis Sativa (CBDS) reported its financial and operating results for the period that ended on March 31st. Their earnings results were somewhat comical as we do not understand how anyone can invest in the company and consider it to be a long-term investment. Highlights from the report include:

  • During the quarter, Cannabis Sativa recorded a $2 million net loss on $1,065 in revenue. The company’s cost of revenue also exceeded the total revenue generated and CBDS reported a $34 gross loss.
  • Professional fees accounted for $1.82 million of the $2 million in operating expenses. The company said these fees were related to the development of business transactions and mostly were non-cash transactions.
  • As of March 31st, Cannabis Sativa reported to have $886,490 of cash on hand ($563,824 as of May 18th) and an accumulated deficit of $ $61,235,463.
  • The company continues to fund itself through the sale of stock and through private offerings. During the quarter, Cannabis Sativa generated $415,136 from the sale of stock and $356,100 from a private offering of stock.

 

 

Pursuant to an agreement between MAPH and Cannabis Wheaton (KWFLF) we were hired for 30 Days to publicly disseminate information about (KWFLF) including on the Website and other media including Facebook and Twitter. We are being paid $150,000 (CASH) for and were paid “0” shares of restricted common shares of Cannabis Wheaton. We may buy or sell additional shares of (KWFLF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 5994
Marijuana Stocks Cannabis Stocks

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage.  Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.

InMed Pharmaceuticals (IMLFF) is a Vancouver-based pre-clinical trial Cannabis-Biotech company that has not only developed a proprietary cannabinoid manufacturing system yet in the process created a highly sought after database, which has mapped the different compounds of cannabinoids to the various diseases that it can address.

This cannabinoid database was designed by (IMLFF) to assist them in their investigative studies and has currently become a core asset as other Cannabis Biotech companies have come knocking on their door willing to offer a hefty sum for this information. Most medical marijuana processors are using THC and CBD because they are easy to extract in large quantities, however there are more than 90 diverse cannabinoid structures that (IMLFF) has plugged into its system. The bioinformatics algorithm has taken those different compounds and screens them against approved drugs, diseases and genetic properties of diseases. It then selects specific cannabinoids that might help regulate that particular disease.

InMed Pharmaceuticals (IMLFF) has created this database “tool” & is saving time and money in the drug research process. It has already helped (IMLFF) to identify two treatments for rare diseases. One for a rare children’s skin disease called epidermolysis bullosa (EB) that has no approved treatments and the other for glaucoma. Chief Executive Officer Eric Adams said, “It’s a very devastating disease and we found out in early testing that this set of cannabinoids treat the major symptoms of this disease giving them a tremendous amount of relief, but it may also reverse the disease, which is something no one has really talked about before.”

Startup Cannabis-Biotechs like InMed Pharmaceuticals (IMLFF) will continue to grow as Marijuana Stocks / Sector continues to evolve into mainstream markets.

0 2559

Marijuana Stocks, Inauguration Day, & Trump’s Bump

Here we are, just after the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.

Click Here To View Full Article

 

Facts Regarding Denver’s New Marijuana In Public Law

Denver has begun working on the country’s first law allowing use in public places like coffee shops and cannabis clubs. However, the details about what those marijuana clubs would look like are still unclear. Here are some answers to questions about the cannabis clubs headed to Denver.

Click Here To View Full Article

 

Veterans In Support Of Medical Marijuana



Indiana American Legion reached an agreement on Sunday that would support a medical cannabis study to treat injuries to military service members, such as traumatic brain injuries and PTSD. The veteran service organization said they are working to urge Indiana legislators to approve the private growth and research of medicinal cannabis and to reclassify marijuana as a drug with potential medical value.

Click Here To View Article

 

 

 PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

3 25480

Today is the final trading day of the year will definitely be one that investors will always remember. The market remains in the positive as companies are better positioned for success. From the advance of the Canadian marijuana industry to election of Donald Trump, there will be a lot for investors to watch next year. We would like to highlight some themes anticipated to play out over 2017.

Consolidation

One of the brightest spots of the marijuana industry in 2016 was the Canadian licensed medical marijuana producer sub-sector. In early December, Mettrum Health (MT.V)(MQTRF) and Canopy Growth (CGC.TO)(TWMJF) announced an agreement where Canopy Growth will gain all of the outstanding shares of Mettrum.

Keep your eyes on the marijuana industry as it is expected to see more deals like this over the next year. The possibility for increase consolidation makes these companies attractive investment opportunities: Aphiria (APH.V)(APHQF), Supreme (SL.V)(SPRWF), OrganiGram (OGI.V)(ORGMF), Emblem Corporation (EMC.V), and Aurora Cannabis (ACB.V)(ACBFF).

Transformation

The biotech sector will be one of the greatest recipients of the legal marijuana movement and recent sector weakness has created opportunities for investors.
GW Pharmaceuticals (GWPH) reported its second Stage Three Clinical trial in September for its Epidiolex product for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). We continue to view GWPH as one of the top marijuana investments due to its capability to convert the cannabis industry through the development of treatments for sickness’ that don’t currently have an approved regimen.

Execution

From the financial structure, investors need to conduct with earnestness. We suggest incorporating some guidelines into your investment blueprint.

To end 2016, we want to highlight some of the stocks investors should watch during next year: Emblem Corporation (EMC.V)(EMMBF), Zoned Properties (ZDPY), Aphria (APHQF), Kush Bottles (KSHB), American Cannabis (AMMJ), Aurora (ACBFF), Reliq Healthcare (RQHTF), Zynerba Pharmaceuticals (ZYNE), OrganiGram (OG.V)(ORGMF), Arcturus Grothstar Tech (AGSTF), MassRoots (MSRT), VPR Brands (VPRB), CV Sciences (CVSI), mCig (MCIG), Canopy Growth (TWMJF)(CGC.TO), Medicine Man Tech (MDCL), GW Pharmaceuticals (GWPH), Lexaria (LXRP), Canabo Medical (CMM.V)(CAMDF), Mettrum Health (MT.V), and VinergyRes (VIN.CN).

0 47135
marijuana

One of the biggest questions we get on MarijuanaStocks.com is “How do I buy Marijuana Stocks?” First, we aren’t financial advisors, but we can offer you a good starting point and some relevant information. We get thousands of emails from our subscribers and created this based off of your inquiries. MarijuanaStocks.com hopes this is a helpful guide to potential investors interested in the Cannabis sector, but we encourage you to continue your research and hopefully you’ll become the next Pot Stock millionaire! Cheers

    0 2394

    Over recent weeks we’ve been shedding more light on the hemp industry and why we see it as an important part of the bigger cannabis space.  Marijuana Stocks, the Wolf of Weed Street and Cheryl Shuman have been working closely with FBEC Worldwide to help develop the first branded hemp infused energy drink for FBEC called the “Wolf Shot Hemp Energy.” The product launch is slated for August 1 and buzz has grown quickly.  Friday FBEC Worldwide was highlighted in an article on TheStreet.com, which focused specifically on the Hemp industry, what it is, why it’s important, and why investors should be paying much more attention to it now more than ever:

    “Hemp Won’t Get You High, But Could Boost Your Portfolio Sooner Than You Think”

    The article discusses the differences between hemp and marijuana citing that though they both are derived from the same type of cannabis plant, their uses couldn’t be more different. Major health benefits from hemp include higher levels of easily digestible protein, longer sustained levels of energy, improved mental focus and even reduction in cardiovascular disease.  The biggest benefit is that though it is limited to growing in the US, using and selling products that have it is not.  Highlighting FBEC Worldwide as a viable option for taking advantage of the growth that this space could see in both short and long terms adds much more legitimacy to the company and shows the true differences between companies planning to do something and companies actually doing it like FBEC Worldwide is; now 3 weeks away from initial product launch.

    Read the full article HERE

      3 10567

      There have been hundreds of marijuana stocks covered in the market, which have captivated the interest of investors. CannaGrow Holdings, Inc. (CGRW) in particular has seen a fair share of attention throughout 2014-2015. It stands to reason that this company has managed to gain momentum after announcing significant developments month over month over the last 3 quarters and has helped to strengthen CannaGrow in becoming a new leader within the industry. But why?

      Initiation and approval of the Colorado Buffalo Ranch project have been the major focal points for the company and over the course of the last 7 months, CannaGrow has acted as a consultant and liaison to NuGro Industries in order to build a leading position in the green house market for Colorado’s marijuana industry.

      The Future For Marijuana Cultivation: Green House Growing

      Conservatives certainly couldn’t have imagines a world where marijuana would be nearing universal legalization and though only 4 states have legalized recreational marijuana, half of the US and the District of Columbia have laws in place that allow medical marijuana to shine. States like New York and Illinois have singled out the drug to be used only by “smokeless” methods and the marijuana industry as a whole – outside of the medical space – has found that nearly have of the industry’s sales are coming by way of edibles.

      No longer is it a matter of “beautiful buds”. Now the real industry is building around extracts. Over $118million worth of marijuana have already been sold in Colorado during the first quarter of 2015 and the market continues to grow month over month according to sales data. Green house growing is preferred when it comes to extracting the most resin from the cannabis plant and the trend to grow weed in greenhouses has come at a time that warehouse space is becoming more expensive and difficult to find. Since voters approved legalizing marijuana for recreational use in 2012, growers have absorbed more than 1 million square feet of industrial space, according to the industrial Market Trends report by Newmark Grubb Knight Frank. The total space occupied by the industry is more than 4 million square feet.

      Therefore, those who have already begun the arduous process of land use approval and conditional use permission will already have a leg up during somewhat of a paradigm shift from bud to extracts. As a liaison and consultant in this niche, CannaGrow can quickly gain market share necessary to carve out a leading position within the space.

      Buffalo Ranch

      Since initiating the submission process for approval of land use in Huerfano County, CannaGrow, acting as a facilitator and liaison, has been able to have approval granted for the project while also continuing its development of the new site. Keep in mind that Colorado may be known for a cooler climate, the state has 300 days of sunshine making it an ideal location for a green house project. Through a series of amendments and multiple meetings with the Huerfano County Planning Commission, both the Land Use Application and Conditional Use Permits were approved and signed which officially marked “the beginning.” This all came together at the end of May and will allow the commercial cultivation of Marijuana on Colorado Buffalo Ranch Filing No. 5-Lot 61, by a licensed Grower that is certified by the State.

      Phase II

      CGRW has been no stranger to price movement. The initial run up from $0.04 to $1.05 just a few months ago has triggered much more attention to be placed on the company and the current projects that it has under development. A much more solidified proof point for CGRW longs will come when the company releases its Phase I and Phase II results. The goal is to become the first large-scale commercial grow operation in Huerfano County Colorado and now that the proper documentation has been procured, the Company can now focus on sourcing materials and manpower for the build out.

      Phase V

      According to CannaGrow, “Phase I & II consists of site grading for the ingress & egress roadways, a 3200 sq. ft. head-works building, six 2300 sq. ft. hoop-houses for outdoor grows, an approximate 3,300 sq. ft. state-of-the-art Nexus Greenhouse that utilizes the most up to date technology for the growing of cannabis.”

      Phasing

      The full build-out of the grow facility will also include a 6,600 sq. ft. “Nexus Greenhouse”, the 3,200 sq. ft. “Olympia Steel Head-Works” building, and sixteen Hoop-houses. Everything from power to water supply has been accounted for and in order to obtain the CUP, the company made sure to bring on Terracon Consultants, Inc., an engineering company specializing in land development, environmental assistance & geotechnical services.

      At the moment, it would appear the company is optimistic about these next steps. In the most recent press release from May, the company stated, “The completion of this Project will provide CannaGrow the basis to begin generating revenues from the licensed Growers sub-leasing the Turnkey Growing Facilities being built to the specifications of CannaGrow consultants, Dr. John P. Janovec and Jason Wells. CannaGrow has already received numerous inquiries from perspective tenants and we are also exploring additional business ventures in the area that could further enhance shareholder value.”

      An analyst report written by BOTEC Analysis Corporation finds that indoor and outdoor grow operations yield roughly 40 grams per square foot of space. Multiple harvests per year would obviously increase this ratio. With the Buffalo Ranch facility, roughly 16,000 square feet of grow space would yield 640,000 grams or about 22,583 oz. At an average wholesale price of $2,000/lb, those ounces could hold more “weight” when it comes to the bottom line.

      The Trade

      Similar to the biotech space, which has been red hot this year, it’s my opinion that speculation and anticipation for the completion of this project could begin to fuel momentum in the market. The current price channel as identified above would suggest that there could be much more room between current price points and the 52-week high of $1.05 where CGRW could respond favorably to positive trading. This is especially in consideration of the recent consolidation the stock has seen as well.

      More news and continued corporate updates could be the catalyst for short bursts of momentum in the market during the near term. As far as the long-term outlook of this is concerned, results of Phase completion will be essential.

      © Copyright 2017 - MarijuanaStocks.com

      Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

      We are your #1 source for all things Marijuana Stocks, Subscribe Below!

      Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
      Close this window
      Ad Placements